Postpartum Readmission Within Six Weeks of Delivery on the Rise

This article originally appeared here.
Share this content:
Postpartum Readmission Within Six Weeks of Delivery on the Rise
Postpartum Readmission Within Six Weeks of Delivery on the Rise

FRIDAY, July 8, 2016 (HealthDay News) -- Postpartum readmission rates rose from 2004 to 2011, according to a study published in the July issue of the American Journal of Obstetrics & Gynecology.

Mark A. Clapp, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues used State Inpatient Databases to evaluate 114,748 postpartum readmissions out of 5,949,739 eligible deliveries occurring within the first six weeks after delivery in California, Florida, and New York (between 2004 and 2011).

The researchers found that the readmission rate increased from 1.72 percent in 2004 to 2.16 percent in 2011. Readmission was more likely among patients who were publicly insured, black, had comorbidities such as hypertension and diabetes, and had a cesarean delivery. Common indications for readmission included infection (15.5 percent), hypertension (9.3 percent), and psychiatric illness (7.7 percent). On average, patients were readmitted seven days after discharge, but this varied by diagnosis: day 3 for hypertension, day 5 for infection, and day 9 for psychiatric disease. Comorbidities (psychiatric disease, substance use, seizure disorder, hypertension, and tobacco use)were the strongest predictors of postpartum readmissions.

"Understanding the risk factors, etiologies, and cause-specific timing for postpartum readmissions may aid in the development of new quality metrics in obstetrics and targeted strategies to curb the rising rate of postpartum readmissions in the United States," conclude the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »